Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun   A 
CETP inhibitor . 
Etymologies
Sorry, no etymologies found.
Support
				Help support Wordnik (and make this page ad-free) by adopting the word dalcetrapib.
Examples
- 
								
Swiss pharmaceutical company Roche also has a CETP drug, called dalcetrapib, in late-stage clinical trials in partnership with Japan Tobacco, in which it sees great potential.
 - 
								
Swiss pharmaceutical company Roche also has a CETP drug, called dalcetrapib, in late-stage clinical trials in partnership with Japan Tobacco, in which it sees great potential.
 - 
								
Swiss pharmaceutical company Roche also has a CETP drug, called dalcetrapib, in late-stage clinical trials in partnership with Japan Tobacco, in which it sees great potential.
 - 
								
Swiss pharmaceutical company Roche also has a CETP drug, called dalcetrapib, in late-stage clinical trials in partnership with Japan Tobacco, in which it sees great potential.
Stuff.co.nz - Stuff 2010
 - 
								
Swiss pharmaceutical company Roche also has a CETP drug, called dalcetrapib, in late-stage clinical trials in partnership with Japan Tobacco, in which it sees great potential.
 - 
								
Roche plans in 2013 to seek regulatory approval of another medicine, called dalcetrapib, which works by boosting levels of good cholesterol.
BusinessWeek.com -- 2010
 - 
								
Swiss pharmaceutical company Roche also has a CETP drug, called dalcetrapib, in late-stage clinical trials in partnership with Japan Tobacco, in which it sees great potential.
 - 
								
Swiss pharmaceutical company Roche also has a CETP drug, called dalcetrapib, in late-stage clinical trials in partnership with Japan Tobacco, in which it sees great potential.
 - 
								
LONDON—Shares in Roche AG were boosted Monday after the Swiss drug maker reported encouraging results from clinical trials of dalcetrapib, a drug designed to raise "good" cholesterol.
Roche Boosted By Drug-Trial Data Sten Stovall 2011
 - 
								
"If, however, one or more of the CETP inhibitors make it to market, they could be multi-billion dollar drugs," they said, adding that dalcetrapib could make a real difference even for a company as large as Roche.
Roche Boosted By Drug-Trial Data Sten Stovall 2011
 
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.